Omeros (OMER) Common Equity (2010 - 2026)
Omeros recorded quarterly Common Equity of -$63.3 million in Q1 2026, up 47.76% quarter-over-quarter from -$121.2 million in Q4 2025, and up 70.34% year-over-year from -$37.2 million in Q1 2025.
Omeros' Common Equity history runs 17 years deep, the most recent figure standing at -$63.3 million for Q1 2026.
- In Q1 2026, Common Equity rose 70.34% year-over-year to -$63.3 million; the TTM figure through Mar 2026 stood at -$63.3 million (up 70.34% YoY), while the FY2025 annual figure was -$121.2 million, up 33.61% from the prior year.
- Common Equity came in at -$63.3 million for Q1 2026 at Omeros, up from -$121.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $85.7 million in Q4 2022 to a low of -$228.7 million in Q2 2025.
- A 5-year average of -$78.9 million and a median of -$63.3 million in 2026 frame the typical range for Common Equity.
- Across the five-year window, Common Equity surged 1215.45% in 2023 and plunged 1005.02% in 2024, its largest moves.
- Omeros' Common Equity stood at $85.7 million in 2022, then tumbled by 129.16% to -$25.0 million in 2023, then plunged by 630.93% to -$182.6 million in 2024, then surged by 33.61% to -$121.2 million in 2025, then surged by 47.76% to -$63.3 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$63.3 million, -$121.2 million, and -$220.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -63.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.33 Mn |
| Dec 31, 2025 | -121.23 Mn |
| Sep 30, 2025 | -220.48 Mn |
| Jun 30, 2025 | -228.69 Mn |
| Mar 31, 2025 | -213.55 Mn |
| Dec 31, 2024 | -182.61 Mn |
| Sep 30, 2024 | -154.17 Mn |
| Jun 30, 2024 | -124.60 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Dec 31, 2023 | -24.98 Mn |
| Sep 30, 2023 | -13.95 Mn |
| Jun 30, 2023 | 20.51 Mn |
| Mar 31, 2023 | 54.94 Mn |
| Dec 31, 2022 | 85.68 Mn |
| Sep 30, 2022 | -46.31 Mn |
| Jun 30, 2022 | -32.70 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | 23.78 Mn |
| Sep 30, 2021 | -262.70 Mn |
| Jun 30, 2021 | -246.30 Mn |
| Mar 31, 2021 | -221.96 Mn |
| Dec 31, 2020 | -120.75 Mn |
| Sep 30, 2020 | -87.33 Mn |
| Jun 30, 2020 | -161.27 Mn |
| Mar 31, 2020 | -131.86 Mn |
| Dec 31, 2019 | -109.02 Mn |
| Sep 30, 2019 | -139.92 Mn |
| Jun 30, 2019 | -130.27 Mn |
| Mar 31, 2019 | -121.02 Mn |
| Dec 31, 2018 | -100.16 Mn |
| Sep 30, 2018 | -89.00 Mn |
| Jun 30, 2018 | -56.30 Mn |
| Mar 31, 2018 | -29.22 Mn |
| Dec 31, 2017 | -2.81 Mn |
| Sep 30, 2017 | 9.21 Mn |
| Jun 30, 2017 | -54.85 Mn |
| Mar 31, 2017 | -48.11 Mn |
| Dec 31, 2016 | -37.45 Mn |
| Sep 30, 2016 | -22.77 Mn |
| Jun 30, 2016 | -49.00 Mn |
| Mar 31, 2016 | -40.74 Mn |
| Dec 31, 2015 | -26.23 Mn |
| Sep 30, 2015 | -9.00 Mn |
| Jun 30, 2015 | 7.93 Mn |
| Mar 31, 2015 | 21.85 Mn |
| Dec 31, 2014 | -42.65 Mn |
| Sep 30, 2014 | -26.59 Mn |
| Jun 30, 2014 | -10.61 Mn |
| Mar 31, 2014 | 5.21 Mn |
| Dec 31, 2013 | -18.38 Mn |
| Sep 30, 2013 | -23.89 Mn |
| Jun 30, 2013 | -12.26 Mn |
| Mar 31, 2013 | -15.86 Mn |
| Dec 31, 2012 | -6.53 Mn |
| Sep 30, 2012 | -820,000.00 |
| Jun 30, 2012 | -20.54 Mn |
| Mar 31, 2012 | -12.68 Mn |
| Dec 31, 2011 | -5.55 Mn |
| Sep 30, 2011 | 4.08 Mn |
| Jun 30, 2011 | 10.02 Mn |
| Dec 31, 2010 | 20.47 Mn |